UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031220 |
|---|---|
| Receipt number | R000035652 |
| Scientific Title | DARZALEX intravenous drip infusion 100 mg, 400 mg Special Drug Use Results Survey (Recurrent or refractory multiple myeloma) |
| Date of disclosure of the study information | 2018/02/09 |
| Last modified on | 2023/08/15 11:44:16 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/02/09 12:03:43 | ||
| 2 | Update | 2020/07/26 19:15:54 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code TEL Name of person sending information Name of person sending information TEL Organization Organization Address Address Tel |
|
| 3 | Update | 2020/08/12 09:38:06 | Recruitment status Date of IRB Last follow-up date |
|
| 4 | Update | 2022/02/14 11:00:58 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator |
|
| 5 | Update | 2022/02/14 11:02:49 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2023/02/13 09:43:06 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 7 | Update | 2023/08/15 11:44:16 | Recruitment status |
